A

Alector (ALEC)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Alector (ALEC)

Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologi... Read more

  • 9.37
  • 9.61
  • 8.93
  • 24.01
  • 12%
  • 133M
  • 0.00
  • 598.90k
  • 753M
  • 6.85
  • -53.3%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.